Variant report
Variant | nsv516648 |
---|---|
Chromosome Location | chr6:5557149-5559059 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:5554838..5557346-chr6:5557615..5559842,2 | K562 | blood: | |
2 | chr6:5549888..5553907-chr6:5554178..5558122,4 | K562 | blood: | |
3 | chr6:5554838..5557346-chr6:5557615..5560510,3 | K562 | blood: | |
4 | chr6:5554838..5557346-chr6:5557615..5560510,3 | K562 | blood: | |
5 | chr6:5554838..5557346-chr6:5557615..5559842,2 | K562 | blood: | |
6 | chr6:5549888..5552504-chr6:5555146..5558122,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10484312 | chr6:5557149-5557150 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs556111715 | chr6:5557182-5557183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs12195090 | chr6:5557210-5557211 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs557588985 | chr6:5557259-5557260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575960413 | chr6:5557265-5557266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543436962 | chr6:5557304-5557305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564714025 | chr6:5557335-5557336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs374704326 | chr6:5557336-5557337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs78679882 | chr6:5557350-5557351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540725895 | chr6:5557353-5557354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555820948 | chr6:5557366-5557367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374573388 | chr6:5557413-5557414 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185984477 | chr6:5557424-5557425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548203845 | chr6:5557470-5557471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563571445 | chr6:5557509-5557510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577469415 | chr6:5557523-5557524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150344172 | chr6:5557551-5557552 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552575686 | chr6:5557557-5557558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76246095 | chr6:5557583-5557584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113130198 | chr6:5557607-5557608 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142446977 | chr6:5557715-5557716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568677202 | chr6:5557760-5557761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs76519142 | chr6:5557774-5557775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557388618 | chr6:5557820-5557821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs575930189 | chr6:5557845-5557846 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190698735 | chr6:5557903-5557904 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs6909169 | chr6:5557914-5557915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183115033 | chr6:5557934-5557935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs4960099 | chr6:5557960-5557961 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs540737944 | chr6:5557988-5557989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs62387183 | chr6:5558018-5558019 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs145983906 | chr6:5558025-5558026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs578241004 | chr6:5558034-5558035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138505261 | chr6:5558092-5558093 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs186364746 | chr6:5558095-5558096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191607669 | chr6:5558107-5558108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564474490 | chr6:5558123-5558124 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs9405847 | chr6:5558173-5558174 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs182532889 | chr6:5558187-5558188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368620081 | chr6:5558217-5558218 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs547082297 | chr6:5558278-5558279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs78098420 | chr6:5558283-5558284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs62387184 | chr6:5558293-5558294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs569350055 | chr6:5558371-5558372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73358247 | chr6:5558416-5558417 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs12201749 | chr6:5558428-5558429 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs570129893 | chr6:5558442-5558443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534292293 | chr6:5558461-5558462 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs116163565 | chr6:5558496-5558497 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs574226539 | chr6:5558509-5558510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Developmental delay | 19490664 | CNVD |
Cancer | 21183584 | CNVD |
Multiple Epiphyseal Dysplasia | 20877625 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Glaucoma | 18694899 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
dysmorphism | 22105932 | CNVD |
psychomotor delay | 22105932 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:5511400-5568200 | Weak transcription | Aorta | Aorta |
2 | chr6:5538000-5573600 | Weak transcription | Left Ventricle | heart |
3 | chr6:5545400-5560000 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
4 | chr6:5550800-5563400 | Weak transcription | Pancreas | Pancrea |
5 | chr6:5550800-5564600 | Weak transcription | Dnd41 | blood |
6 | chr6:5551000-5566000 | Weak transcription | Primary T cells from cord blood | blood |
7 | chr6:5551000-5566200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr6:5551600-5575200 | Weak transcription | Primary B cells from cord blood | blood |
9 | chr6:5552400-5564600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr6:5553200-5567800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr6:5555000-5557400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr6:5555000-5564600 | Weak transcription | H1 Cell Line | embryonic stem cell |
13 | chr6:5555200-5563400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
14 | chr6:5555600-5563400 | Weak transcription | H9 Cell Line | embryonic stem cell |
15 | chr6:5557400-5557800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr6:5557600-5558600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
17 | chr6:5557800-5563400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |